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Abstract
Pathogenesis studies of SIV infection have not been performed to date in wild monkeys due to difficulty in collecting and
storing samples on site and the lack of analytical reagents covering the extensive SIV diversity. We performed a large scale
study of molecular epidemiology and natural history of SIVagm infection in 225 free-ranging AGMs from multiple locations
in South Africa. SIV prevalence (established by sequencing pol, env, and gag) varied dramatically between infant/juvenile
(7%) and adult animals (68%) (p,0.0001), and between adult females (78%) and males (57%). Phylogenetic analyses
revealed an extensive genetic diversity, including frequent recombination events. Some AGMs harbored epidemiologically
linked viruses. Viruses infecting AGMs in the Free State, which are separated from those on the coastal side by the
Drakensberg Mountains, formed a separate cluster in the phylogenetic trees; this observation supports a long standing
presence of SIV in AGMs, at least from the time of their speciation to their Plio-Pleistocene migration. Specific primers/
probes were synthesized based on the pol sequence data and viral loads (VLs) were quantified. VLs were of 104–106 RNA
copies/ml, in the range of those observed in experimentally-infected monkeys, validating the experimental approaches in
natural hosts. VLs were significantly higher (107–108 RNA copies/ml) in 10 AGMs diagnosed as acutely infected based on SIV
seronegativity (Fiebig II), which suggests a very active transmission of SIVagm in the wild. Neither cytokine levels (as
biomarkers of immune activation) nor sCD14 levels (a biomarker of microbial translocation) were different between SIV-
infected and SIV-uninfected monkeys. This complex algorithm combining sequencing and phylogeny, VL quantification,
serology, and testing of surrogate markers of microbial translocation and immune activation permits a systematic
investigation of the epidemiology, viral diversity and natural history of SIV infection in wild African natural hosts.
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Introduction
Over 40 African nonhuman primate (NHP) species are
naturally infected with simian immunodeficiency viruses (SIVs)
[1–3]. Among these, African green monkeys (AGMs) (Chlorocebus
genus) are the most numerous, most widely geographically spread
and most commonly infected with SIV in the wild [1].
According to Groves [4,5], AGMs are divided into species that
are phenotypically and geographically distinct: vervets (C. pygery-
thrus) are the most widely spread in East and Southern Africa,
ranging from the eastern Rift Valley in Ethiopia, Somalia and
extreme southern Sudan to the Cape region in South Africa;
grivets (C. aethiops) inhabit the area east of the White Nile in
Ethiopia, Somalia from Khartoum to Mongalla, Eritrea and
Ethiopia south to the Omo; tantalus monkeys (C. tantalus) are the
prevalent species in north Central Africa from Ghana to Sudan
and Kenya; green monkeys (C. sabaeus) reside in West Africa from
Senegal to the Volta River, and have been introduced to Cape
Verde Island as well as to the Caribbean [4]. A fifth AGM species,
the malbrouck (C. cynosuros), is located in Central and South-
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Central Africa ranging from the Albertine Rift in the Democratic
Republic of Congo to the Atlantic coast and Northern Namibia
and Zambia. Finally, a sixth species, the Bale Mountain vervet (C.
djamdjamensis) has a very limited distribution in the bamboo forests
of highland Ethiopia. This taxonomic classification, however, is
not universally accepted [6].
With the exception of the malbrouck and the Bale mountain
vervet, each of the AGM species have been shown to be infected in
the wild with species-specific SIVagm (defined as SIVagmVer,
SIVagmGri, SIVagmTan and SIVagmSab) [7–11], with the
reported prevalence rates ranging from30 to 50% [8,12–19].
Phylogenetic analyses of SIVagm strains have shown that the
spectrum of genetic diversity of SIVagm surpasses that of other
primate lentiviruses [7,9,19–21], presumed to be due to codiver-
gence/host-dependent evolution (i.e., the evolution of SIVagm from
grivet, vervet, tantalus and green monkey species occurred in
concert with host speciation) [8,10,11]. Together, these findings
indicate that AGMs have coexisted with SIVagm for a long period
of time, possibly even before their radiation and divergence from
their common ancestor, approximately 1.5–3 million years ago [22].
Pathogenesis studies support an ancient coevolutionary relation-
ship by showing that SIVagm are highly adapted to their hosts and
that SIVagm-infected AGMs generally do not progress to AIDS
[23,24]. Key features of SIVagm infection in AGMs, as established
by experimental studies performed on captive AGMs, include: (i)
active viral replication, with set-point viral loads (VLs) similar to or
higher than those found in HIV-infected patients [25–29]; (ii)
significant depletion of CD4+ T cells during acute infection
[25,26,30,31], followed by rapid restoration to near preinfection
levels in the peripheral blood [17,25,26,30,31] and delayed and
incomplete restoration at mucosal sites [30]; (iii) maintenance of the
balance between Th17 and T regulatory cells, due to preservation of
the Th17 cell subset [32]; (iv) vigorous but transient inflammatory
responses to the virus during acute infection, which are resolved
with the transition from acute-to-chronic infection [30,33,34]; (v)
productive infection of short-lived cells [31]; (vi) partial control of
virus replication by the adaptive immune responses to SIV [35–
41];(vii) no significant increase in CD4+ T cell apoptosis during
either acute or chronic infection [30,42,43]. These normal levels of
CD4+ T cell apoptosis together with preservation of Th17 cells
probably allow AGMs to avoid enteropathy, breaches in the
mucosal barrier and subsequent microbial translocation (MT) [30],
as well as chronic immune activation and disease progression, while
allowing CD4+ T cell recovery in the presence of high VLs [30,44].
Furthermore, similar to other natural hosts of SIVs [45], AGMs
have a number of adaptations that spare CD4+ T cells from virus-
mediated killing in vivo. These features include a lower fraction of
CD4+ T cells expressing the CCR5 coreceptor [46,47] and down-
regulation of the CD4 molecule by T helper cells as they enter the
memory cell pool [48–50]. Altogether, these adaptations support
the concept that the benign course of SIV infection in natural hosts
is the result of coevolution over millennia [1,51].
The ancestry of SIV infections and the codivergence of SIV
types with their host species, however, could be accounted for by a
model of preferential host-switching [52]. In the case of AGMs it
has recently suggested that the phylogenetic profiles of SIVagm
can be explained by a pattern of west-to-east transmission of the
virus across existing AGM geographic ranges and that the viral
divergence may have occurred more recently than previously
suggested [53]. This study included only a small number of SIV
strains covering a limited geographical distribution, which may
have biased a full appreciation of the phylogenetic relationships
and ancestry of SIVagm from different AGM species and likely
altered the timing calculations for SIVagm emergence. A recent
study in which calibration of molecular clocks was based on
biogeographical features, reported that SIVs are actually older
than estimated based on molecular clock calculations only [2].
The major focus of studies carried out thus far in wild African
NHP species has been on identification and characterization of
species-specific SIVs [54,55]. A common denominator of these
studies has been the difficulty of obtaining samples from wild
animals and the lack of research infrastructure for pathogenesis
studies in the field. Several approaches have been used to
circumvent these limitations: (i) estimation of the SIV prevalence
in captive monkeys, which significantly underestimates the preva-
lence in the wild, as most monkeys are captured at a young age and
maternal-to-infant transmission rates are low in African NHP
species [56]; (ii) use of bush meat samples. These are easy to obtain
and thus this strategy has proven instrumental in identifying
numerous SIVs and generating meaningful prevalence data [2,57–
62]. However, bush meat samples tend to be from adult populations
and do not permit viral isolation or assessment of critical parameters
of infection, such as VLs, immunophenotyping or assessment of the
levels of immune activation; and (iii) use of noninvasive sampling
(i.e., collection of fecal or urine samples), which has also been
instrumental in assessing the prevalence of SIV infection in natural
hosts, most notably in identifying and characterizing the animal
reservoir of pandemic HIV strains [63–67]. However, similar to the
use of bush meat samples, noninvasive samples cannot be used to
assess key parameters of SIV infection. Thus, although SIVs have
been identified and characterized for over two decades, studies of
the natural history of SIV infection in the wild have only been
performed at a cursory level [1,54,68].
Here, we performed for the first time in an African NHP host, a
comprehensive large-scale characterization of the epidemiology
and natural history of SIV infection in vervet monkeys living freely
in different parks, nature reserves and farms from three provinces
of the Republic of South Africa, to validate the virological and
immunological features of experimental studies in natural hosts.
Results
Prevalence of retroviral infections in vervets from South
Africa
Blood samples were collected from two hundred and twenty-five
wild-trapped vervets over a 4.5 month period. Details on monkey
Author Summary
We simultaneously assessed, for the first time in a natural
host, the epidemiology, diversity and natural history of
SIVagmVer infection in wild vervet populations from South
Africa. We report that African green monkeys (AGMs) have
likely been infected with SIVagm for a long period, ranging
from the time of their speciation to Plio-Pleistocene
migrations, refuting previous molecular clock calculations
suggesting SIVagm to be of recent occurrence. As a result
of virus-host coadaptation, SIVagmVer infection is charac-
terized by a lack of disease progression in spite of robust
viral replication. We show that very active SIVagm
transmission in adult AGMs contrasts with a very limited
transmission to their offspring, in spite of massive
exposure to SIVagm both in utero and through breastfeed-
ing. The observation that some AGMs remain uninfected in
spite of life-long exposure to SIVagm identifies wild
vervets as an acceptable animal model for the exposed
uninfected individuals, which can be used to identify
correlates of resistance to HIV/SIV infection.
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capture and sample collection are presented as Supplementary
information. The samples included represent 11 populations from
9 parks, game reserves and farms located in 3 provinces of South
Africa–the Free State, KwaZulu-Natal, and Eastern Cape–
covering majority significant proportion of vervet habitat in this
region (Figure 1). Both sexes were equally represented. Samples
from infants (,1 year old) and juvenile AGMs were included
(Figure 1).
Diagnosis of SIVagmVer infection was performed by PCR,
which allows for the evaluation of SIVagm diversity in addition to
prevalence estimates. Also, in infants, PCR permits the diagnosis
of infected offspring (as opposed to serological assays which are not
specific, i.e., may also detect passively transmitted maternal
antibodies). RNA was extracted from all plasma samples and
subjected to RT-PCR analysis using consensus primers designed to
amplify a 600-bp fragment in pol integrase and a 900-bp fragment
in the gp120 gene encompassing the V3–V5 regions and the 59
end of the gp41 gene. In addition, gag PCR (846 bp fragment in
the p24 gene) was performed on selected samples from each
location. This analysis identified 103 AGMs that were virion RNA
(vRNA) positive using one, two or three primer sets (Table 1),
giving an overall prevalence of SIVagmVer infection of 59% (73/
123) in females and 29% (30/102) in males, in the range of those
found in previous reports in AGMs [8,15,17]. Prevalence levels
were relatively similar between different locations (Table S1) and
higher than in a cohort of semifree animals (Table S2). SIVagm
prevalence was very uneven in different age groups: 7% (3/44) in
infants (males: 4%, 1/26; females: 11%, 2/18), 16% (9/58) in
juveniles (males: 15%, 5/34; females: 21%, 4/21) and 71% (91/
128) in adults (males: 57%, 24/42; females: 78%, 67/86). Thus,
we confirmed on a very large number of samples previous results
reporting that a dramatic increase in the SIVagm prevalence and
incidence occurs with the passage to sexual maturity in AGMs
[16]. Interestingly, and different from previous reports, we
identified cases of SIVagmVer infection in very young AGMs,
which may be suggestive of vertical transmission of the virus in the
wild.
Genetic diversity of SIVagm in vervets from South Africa
To determine the relationships of the newly identified SIVagm
strains to each other and to previously characterized SIVagm
strains, we constructed phylogenetic trees from amplified pol and
Figure 1. Satellite map of the Republic of South Africa indicating the geographical origin of the samples included in this study.
Vervet samples from areas from three provinces (Free State, KwaZulu Natal and Eastern Cape) were included, as indicated. Sex and age-group
coverage is illustrated.
doi:10.1371/journal.ppat.1003011.g001
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env nucleotide sequences using a maximum likelihood approach
(Figure 2 and Figure S1). While newly identified SIVagmVer
strains naturally infecting vervets from South Africa exhibited a
high genetic diversity, with average genetic distances in the pol
gene of 16.264.8%, phylogenetic analyses also identified SIVagm
strains that differed in less than 2% of their pol and env nucleotide
sequences, indicating epidemiologically linked infections (Figure 2
and Figure S1). In general, strains originating from vervets from
the same area clustered together (Figure 2) with a few exceptions
that are probably due to male migration between groups when
they reach sexual maturity.
As expected, phylogenetic analyses showed that SIVagmVer
strains from South Africa clustered with the SIVagmVer reference
strains (Figure 2 and Figure S1) and were only distantly related to
the SIVagm strains from other AGM species (Figure 2). Further-
more, the newly characterized SIVagmVer strains from South
Africa formed a subcluster within the SIVagmVer group, in
agreement with the fact that all the reference strains available thus
far have a distinct geographical origin, being collected from
vervets in Kenya, Ethiopia and Tanzania [9,19,20]. Average
genetic distances between the reference SIVagmVer strains
(collected from Ethiopia, Kenya and Tanzania) and the newly
characterized SIVagmVer strains were 25.462.1%, significantly
higher than the overall genetic distances between South African
strains (p,0.0001) (Table S3).
Similar to previous reports [66], comparison between the pol
and env tree topologies showed numerous differences (Figure 2 and
Figure S1), indicating extensive recombination within the SIVagm
radiation (Figure S2). Mosaic branches occurred both near the tips
of the trees and deeper in the trees, indicating that extensive
recombination events have occurred throughout the evolutionary
history of SIVagmVer [66]. This high frequency of recombina-
tions between divergent SIVs indicates that SIVagm coinfection
and/or superinfection occur frequently in wild vervets.
Remarkably, a geographically-associated clustering pattern can
be defined for the South African SIVagmVer strains, with all but
one of the SIVagmVer sequences from AGMs inhabiting different
areas in the Free State forming a monophyletic cluster in the
phylogenetic trees (Figure 2 and Figure S1).
Bootstrap analysis strongly supports a single origin of the Free
State cluster, however parental nodes were associated with lower
bootstrap support in the pol tree, suggesting ambiguity as to where
the root of the Free State cluster should be placed. Lower
bootstrap support may be indicative of recombination; a
SplitsTree analysis shows that some KwaZulu-Natal sequences
are likely to be recombinants of East Coast sequences, indicating a
mixing between these two populations (Figure S2).
Interestingly, the SplitsTree analysis also identified one Free
State sequence (VMT17083-IM-Gariep_FS) as potentially stem-
ming from a distant recombination event with outgroup
SIVagmVer sequences, this may suggest that this sequence is in
fact a recombinant with an unknown parent (Figure S2).
The most likely explanation for these phylogenetic relationships
is that the Drakensberg Mountains acted as a barrier to separate
the vervet populations. We estimate that this separation could
have occurred in a time frame ranging from 3 million years ago
(during the AGM spread throughout sub-Saharan Africa) to
100,000 years ago (during the mass migrations that occurred in the
Plio-Pleistocene glacial periods). We tested this hypothesis by
calibrating a relaxed molecular clock to specify the time to the
most recent ancestor (TMRCA) of the SIVagm samples
surrounding the Drakensberg Mountains range to a time-frame
spanning 100,000 to 3,000,000 years since the present for the env
tree, and in the pol tree we additionally included SIV strains from
several species and further calibrated the tree based on isolates
from Bioko Island [2]. According to this analysis, divergence of the
Free State lineage is likely to be closer to the 100,000 year mark,
with mean most recent common ancestor (MRCA) for the South
African SIVagm strains estimated at 329 thousands of years (kYa)
(with 95% highest posterior density of 100–1,077 kYa) and 104
kYa (100–112 kYa), in the env tree (Table S4) and pol tree (Figure 3
and Table S4), respectively. This analysis places the root of the
SIV tree older than previous studies [2], with the env tree giving a
time estimate of SIV endemicity in simian species for 790 kYa
(range: 151–2,595 kYa), and the pol tree indicating 248 kYa (range:
189–317 kYa) (Table S4).
Analyses of the env gene
SIVagmVer envelope sequences (909 bp) encompassing the
V3–V5 regions of the surface (SU) envelope glycoprotein and the
59 end of the transmembrane (TM) domain were amplified by
nested PCR from 48 plasma samples. Alignment of their deduced
amino acid sequences with those of published reference SIVagm
strains from all four species of AGMs identified hypervariable
(V3–V5) as well as conserved envelope domains (Figure 4), as
reported previously [10].
Regions corresponding to HIV-1 envelope domains of known
function, including the envelope glycoprotein precursor cleavage
site, the CD4 binding domain and the viral fusion peptide (N-
terminus of gp41) were all highly conserved (Figure 4). Also
conserved were the majority of cysteine residues (11 of 12) and, as
reported previously [10,18], there was very little sequence
variability in the region that corresponds to the hypervariable
V3 loop of HIV-1. Pairwise amino acid sequence comparisons
were performed to examine the extent of SIVagmVer genetic
diversity in the PCR amplified envelope fragment. As for the pol
sequence analysis, env analysis revealed that SIVagmVer sequences
collected from monkeys in the Free State form a distinct cluster
from the monkeys living on coastal areas from both KwaZulu
Natal and Eastern Cape provinces (Figure S1). This separate
cluster was supported by both specific sequence signatures in the
Free State-originating strains and by smaller genetic distances
between these strains (Figure 4 and Figure S1).
Table 1. Age- and sex-related prevalence of SIVagmVer in wild vervets from South Africa.
Females Males
Total SIV+ Prevalence (%) Total SIV+ Prevalence (%)
Infants 18 2 11 26 1 4
Juveniles 19 4 21 34 5 15
Adults 86 67 78 42 24 57
doi:10.1371/journal.ppat.1003011.t001
SIVagmVer Infection in Wild African Green Monkeys
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Figure 2. SIVagmVer diversity in wild AGMs from different parks and game reserves in the Republic of South Africa. Maximum
likelihood tree for pol gene. Sequences are colored depending on the region in which the sequences were sampled, with red indicating sequences
from Free State, green indicating sequences from KwaZulu-Natal, and blue indicating sequences from Eastern Cape territories. Reference SIVagm
strains from vervet monkeys in Kenya are shown in black. The tree is based on a 592 bp pol sequence alignment (after gap-containing sites were
removed). Maximum likelihood estimates were performed using 1000 replicate bootstrap analysis. Internal nodes indicate level of support values for
internal branching. Bar represents number of amino acid replacements (0.09) per site. The strain nomenclature includes the identification number,
monkey status (M-male, F-female; I-infant; J-juvenile and A-adult),and the site and state of origin (FS-Free State; KZN-KwaZulu Natal; EC-Eastern Cape).
Putative heterosexual transmission cases documented to be of recent occurrence based on VL and serology testing are underlined. Putative
maternal-to-infant transmission cases are boxed.
doi:10.1371/journal.ppat.1003011.g002
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Thus, sequence analysis identified: (i) a high diversity of SIVagm
in South Africa, with the viruses collected from AGMs in the Free
State forming an independent cluster, clearly separated from the
strains collected from AGMs on the Indian Ocean coast; (ii) high
frequency of recombination, suggestive of extensive transmission
of the virus; and (iii) occurrence of highly related strains, suggestive
of identifiable transmission clusters.
Assessment of the natural history of SIVagmVer infection
in wild AGMs
It is generally assumed that SIV infection is nonpathogenic in
natural hosts [23,51,56]. However, this paradigm was recently
challenged by studies demonstrating that SIVcpz has a substantial
negative impact on the health, reproduction and lifespan of
chimpanzees in the wild [68–70]. We therefore took advantage of
this unique sample set to assess for the first time the natural history
of SIV infection in a natural host monkey species in the wild.
Clinical data
During sample collection, all included AGMs had a thorough
clinical assessment. None of the vervets presented with any of the
clinical signs associated with SIV infection, including fever, weight loss,
lymphadenopathy or opportunistic infections. Although the cross-
sectional nature of this study precludes assessment of changes in
monkey weight and thus a direct assessment of weight loss, we
performed comparative analyses of the bodymass index (BMI) between
SIV-positive and SIV-negative monkeys and showed that SIV status
does not have an impact on normal weight of wild vervets (Figure S3).
Genotypic assessment of the coreceptor usage of
SIVagmVer strains from South Africa
Coreceptor usage by the different SIV strains may have a significant
impact on the natural history of SIV infection in the wild. Previous
studies reported that SIVagmSab strains have the ability to use the
CXCR4 coreceptor for viral entry, in addition to CCR5 [26]. Since
the amounts of plasma available from the AGMs in South Africa
precluded in vitro phenotypic testing of coreceptor usage by these new
strains, we estimated coreceptor use in silico by analyzing the V3 region.
V3 sequence impacts SIVmac and SIVagm tropism [71–73].The
algorithms for genotypic assessment of coreceptor usage based on the
HIV-1 V3 sequences cannot be implemented for SIV [74,75]. We
therefore assessed the overall net charges of the V3 loop for these
sequences and found that all the viruses exhibited the sameV3 loop net
charge (+7), similar to that of other SIV strains that are documented to
use CCR5 [1]. No significant differences in the potential N-
glycosylation sites located in the V3–V5 region could be documented
for the newly derived SIVagmVer strains from South Africa (Figure 4).
We therefore inferred that SIVagmVer strains identified here likely use
CCR5 as the major coreceptor for entry, similar to the majority of SIV
isolates [26,40,76].
Staging of SIVagmVer infection in the wild: VL and
serological testing
The levels of chronic viral replication are highly predictive of
the outcome of HIV-1 infection [77,78] and as we previously
reported, may also predict the outcome of SIV infection in natural
hosts, as the handful of African NHPs reported to progress to
AIDS exhibited higher chronic VLs than nonprogressors [79]. To
date, VLs in natural hosts of SIVs such as AGMs, sooty
mangabeys and mandrills have only been assessed in either
experimentally intravenously-infected monkeys [25,80–84] or
captive naturally infected monkeys [17,28,29,79,85,86]. Only
one study reported VLs in wild African monkeys on a very limited
number of samples [85].
We used the generated SIVagmVer pol sequences to design
specific primers and probes for viral quantification. The integrase
region amplified by the pol primers used in our study is relatively
well conserved; thus, the primers and probe had an excellent
coverage of SIVagmVer diversity. We then quantified the VLs in
87 available samples from the 103 SIVagmVer-infected vervets.
Results are shown in Figure 5. Plasma SIVagmVer VLs ranged
from 104 to 107 copies/ml and were higher in the juvenile than in
adult AGMs, albeit this difference was not statistically significant.
At least 23 of the 49 SIVagm-infected dams for which the VLs
were available (47%) were documented as lactating at the time of
sampling (Figure 5). The VLs of lactating dams are detailed in
Figure 5 and demonstrate a large exposure of infant AGMs to SIV
through breastfeeding.
While VLs of the majority of SIVagm-infected animals fell
within a relatively close range, consistent with the range previously
reported in experimentally infected African NHPs that are natural
hosts of SIV [27], VLs were higher than expected in approxi-
mately 10% of vervets (Figure 5). Since such high VLs were
observed in the majority of juvenile AGMs, we reasoned that they
may be recent infections [27].
High levels of viral replication observed around the peak of VLs
during acute HIV/SIV infection generally occur prior to
seroconversion [87] and correspond to the Fiebeg II stage of
HIV-1 infection [87]. Hence, to stage the SIVagm infection in
AGMs with high VLs, we further designed a gp41 peptide ELISA
and assessed the levels of anti-SIVagm antibodies in the available
samples. As shown in Figure 6, the majority of SIVagm-infected
AGMs harbored detectable levels of anti-gp41 antibodies.
Conversely, most of the AGMs presenting with high VLs were
seronegative. Altogether, these results strongly suggest that AGMs
with high VLs were in the acute stage of infection [87]. Note,
however, that definitive proof in support of this conclusion would
rely on serial sampling and demonstration of seroconversion and
partial control of viral replication [87].
Interestingly, serological testing showed that the majority (72%)
of the plasma samples collected from infant AGMs were
seropositive for SIVagm (Figure 6), while SIVagm could be
amplified from only 3 of the infant samples (Figure 2 and Table 1),
suggesting passive transfer of maternal antibodies and document-
ing massive in utero exposure of AGM offspring to SIVagm.
In conclusion, monitoring the viral replication and the anti-
gp41 antibodies in SIVagmVer-infected AGMs allowed us to
demonstrate that: (i) naturally occurring chronic SIV infection in a
natural host is characterized by high VLs, which are in the same
range as in experimentally-infected animals [27]; (ii) SIVagm
transmission is very active in the wild; and (iii) the relatively low
Figure 3. Molecular clock trees for pol gene based on the newly derived SIVagmVer sequences from vervets in South Africa. Relaxed
molecular clock tree show the ultrametric divergence pattern between lineages. Calibration was based on internal nodes indicated with a red circle,
by setting priors that span the presumed divergence MRCA date ranges, 100,000–3,000,000 years for SIVagm sequences surrounding the
Drakensberg Mountains in South Africa, and 10,00061,000 for SIVdrl sequences sampled from Bioko Island [2]. Internal nodes show divergence date
estimates. Sequences are colored based on the territory from which they were sampled, with South African sequences colored red, green and blue,
for Free State, KwaZulu Natal and Eastern Cape, respectively, and Bioko sequences colored in yellow.
doi:10.1371/journal.ppat.1003011.g003
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prevalence of SIVagm infection in offspring strongly contrasts with
their massive in utero and breastfeeding exposure.
Assessment of the integrity of mucosal barrier
Both SIV-infected AGMs and SMs were reported to maintain
the integrity of mucosal barrier and thus to control MT [30,84],
which has been reported to be the main factor behind increased
immune activation that drives disease progression in pathogenic
HIV/SIV infections [88,89]. To assess MT in wild vervets, we
tested the levels of sCD14 as a surrogate biomarker. As shown in
Figure 7, the levels of sCD14 were similar between SIV-infected
and SIV-uninfected AGMs and were in the range of those we
Figure 4. Alignment of partial envelope protein sequences from multiple SIVagmVer isolates. PCR-derived env nucleotide sequences
were translated, aligned with previously reported SIVAGM env sequences [133] and compared with a consensus sequence generated by BioEdit. Dots
denote sequence identity with the consensus sequence, while dashes represent gaps introduced to optimize the alignment. Triangles (‘) denote N-
linked glycosylation sites. Bullets (N) mark CD4 binding sites. V3, V4 and V5 designate hypervariable SIVagm Env domains as previously described
[10]. The envelope precursor cleavage site is indicated by an arrow above the consensus sequence. Strain nomenclature includes the identification
number, monkey status (M-male, F-female; I-infant; J-juvenile and A-adult), and the site and the state of origin (FS-Free State; KZN-KwaZulu Natal; EC-
Eastern Cape).
doi:10.1371/journal.ppat.1003011.g004
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previously documented in captive uninfected and experimentally-
infected AGMs. Even the samples collected from acutely infected
monkeys did not show a significant increase in the levels of sCD14,
in agreement with our previous results from captive experimen-
tally infected AGMs [30,90], and suggesting that wild SIVagm-
infected AGMs maintain the integrity of the mucosal barrier.
Cytokine and chemokine testing
Finally, to assess the immune activation status between
SIVagm-infected and uninfected AGMs in the wild, we measured
and compared the levels of a large array of cytokines and
chemokines in the available samples collected from the two groups
in a Luminex assay. As shown in Figure 8, there was no significant
increase in the cytokine/chemokine levels between SIV-infected
and uninfected AGMs, with the exception of IL-6. In general,
these cytokine/chemokine levels were in the same range of those
previously reported by us and others [34] in captive uninfected
and experimentally-infected AGMs during the chronic stage of
SIVagm infection. This difference was mainly due to elevated
levels of IL-6 in four of nine acutely-infected monkeys tested.
When these samples were removed from the analysis, there were
no significant differences in the levels of IL-6 between infected and
uninfected AGMs. The increases in IL-6 probably reflect the
transient increase in the levels of immune activation previously
reported to occur during acute SIV infection in natural hosts
[30,33,34,91].
Thus, our analyses demonstrate the maintenance of the mucosal
barrier and the lack of increased immune activation in acutely and
chronically-infected AGMs in the wild. Immune activation being
the major determinant of disease progression in pathogenic HIV/
SIV infections, our results further support the clinical assessment
of a benign outcome of SIV infection in wild AGMs.
Discussion
AGMs are the largest reservoir of SIV in the wild [23] and one
of the main animal models for the study SIV pathogenesis in
natural hosts [23,92]. However, so far no study has systematically
investigated the prevalence and incidence of SIVagmVer in
vervets and whether the natural history of SIVagm infection in
wild free living animals differs from that of captive populations. To
address these two key questions, we performed a large-scale
analysis of SIVagmVer in wild vervets from the Republic of South
Africa. Using only 0.5 ml of plasma and a new complex algorithm
combining sequencing and phylogeny with virus quantification,
serology, and assessment of surrogate markers of microbial
translocation and immune activation, we concomitantly investi-
gated, for the first time in a wild natural host African NHP
monkey species, SIV diversity and evolution simultaneously with
epidemiology and natural history. The strategy outlined here
enables a systematic investigation of the natural history of SIV
infection in wild natural hosts.
Epidemiologic considerations
Vervets are abundant throughout East Africa along the Indian
Ocean coast. However, most studies carried out thus far focused
only on vervets from Northeast Africa (Kenya, Ethiopia and
Tanzania) [14], and reported an SIVagmVer prevalence rate of
Figure 5. Cross-sectional analysis of SIVagm RNA levels in
plasma of naturally infected AGM using a real-time RT-PCR
assay. No significant difference could be observed between infant,
juvenile and adult AGM or between female and male monkeys. Samples
with high VLs assessed as acutely infected are shown. VLs of lactating
dams are depicted in lighter colors. Detection limit: 100 copies/ml.
doi:10.1371/journal.ppat.1003011.g005
Figure 6. anti-SIVagmVer IgG antibody seroprevalence in
vervets from South Africa. Testing was done by peptide ELISA
(mapping the immunodominant region of gp41 of SIVagmVer).
Samples were grouped based on PCR and VL quantification results as
originating from uninfected vervets, SIV-infected vervets with VLs.106
SIVagmVer RNA copies/ml, SIV-infected vervets with VLs ranging from
104 to 106 SIVagmVer RNA copies/ml and samples from infant vervets.
Samples in the latter group are negative by PCR but show different
levels of anti-SIVagm IgG, therefore being suggestive of transplacental
crossing of maternal antibodies. Values on the Y-axis represent fold
increases of the optical density of the samples (measured at 492 nm)
over the cut-off value (established at an optical density of 0.2).
doi:10.1371/journal.ppat.1003011.g006
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50% [17]. Conversely, our large-scale survey of SIVagm
prevalence and diversity in vervets includes samples collected
from all age groups and from multiple locations in South Africa.
We confirm that the overall prevalence of SIVagm infection in the
wild is high (46%), supporting the notion that SIVagm is uniformly
distributed and widespread in AGMs [15,16,93]. These preva-
lence levels are similar to those previously reported for sooty
mangabeys [66,94,95] and mandrills [96], which are among the
most commonly infected NHP species known to date. For the first
time, we document that one of the reasons for such extensive
spread of SIV in wild vervets is the high steady-state SIVagm
replication which probably facilitates virus transmission between
AGMs through sexual contact [97].
SIVagm prevalence is higher in AGM females than in males.
This difference is not surprising given that SIVagm transmission
has lower efficacy through the foreskin compared to vaginal
exposure [98] and that most males are expected to have
significantly lower exposure, as only a few attain the dominance
status necessary for sexual access to breeding females [99]. Note,
however, that the robust levels of prevalence in males may be
explained by the observation that despite the sexually restrictive
nature of male dominance hierarchies in vervets, many subordi-
nate males in multimale, multifemale groups can gain sexual
access to females through a number of strategies [100–102], and
thus become infected [103]. The relatively long breeding season,
which lasts up to three months, may also reduce the ability of the
alpha male to effectively monopolize fertile females, and increase
the chances of transmission through sexual contact in subordinate
males [104]. Furthermore, SIVagm transmission between males
probably also occurs through aggressive, blood-exposing contacts
for dominance, similar to other species [105], as many of the males
sampled had open wounds or scars from such contact. Addition-
ally, many females show marked aggression against dispersing
males attempting to migrate into their social groups, often
resulting in serious injury, providing another route of infection
between males and infected females [106].
The very uneven distribution of SIVagm infection among
different age groups strongly supports the sexual route as the main
transmission route for SIVagm, together with a significantly less
effective maternal-to-infant transmission. The low rates of mother-
to-infant transmission are paradoxical, as our study documented
large SIVagm exposure of the offspring both in utero and through
breastfeeding. The rates of maternal-to-infant transmission in wild
AGMs are significantly lower than the 35 to 40% mother-to-infant
transmission rates reported in HIV infection (http://www.unaids.
org) or 40–70% transmission rates in rhesus macaques [107] and
are likely the result of virus-host coadaptation [97]. It is also
possible that, similar to previous reports in captive sooty
mangabeys and AGMs [108,109], SIV infection of infant AGMs
is associated with significantly lower levels of viremia than
infection of adult monkeys, which may therefore go undetected
by our assay.
Also conceivable is that, in addition to sexual and maternal-to-
infant routes, a nonnegligible proportion of SIVagmVer transmis-
sions occur through biting or fighting, as injuries are frequent (in
our study sample, 10% of vervets showed signs of recent injuries
that could result in exposure, such as deep lacerations). Injuries
preponderantly occur during the mating season, due to both male
transfer and to contests for dominance between males, and are
usually cleaned by licking, which may involve many different
individuals and may explain identification of near-identical viruses
in vervets which are not direct mating partners. Studies have
shown that monkeys are highly susceptible to SIV infection
through oral exposure [110,111], and the high levels of systemic
viral replication documented in wild vervets may facilitate oral
transmission during wound cleaning.
At least 10% of the cases of SIVagmVer infection in our group
were recent infections (defined by high levels of viral replication
close to the peak VL and negative serologies). Recent infections
tend to occur in a narrow time frame (10–12 days postinoculation
in experimentally infected macaques and African NHPs [27] and 3
weeks postinfection in HIV-1-infected patients [87]); therefore our
results point to relatively high rates of SIVagm transmission in the
wild. Note, however, that most transmissions are probably
condensed in the time frame of the mating season, and thus the
overall incidence of SIV infection in AGMs is not as high as
suggested by our cross-sectional analysis.
Virus diversity and evolutionary considerations
Our study identified a significant degree of divergence between
strains collected from relatively homogenous groups of vervets,
similar to previous reports for other species of African NHPs hosts,
such as mandrills and sooty mangabeys [61,66,95,96]. Also, we
have identified closely related strains, suggestive of identifiable
chains of transmission. In some instances, such highly related
strains were observed in mother-offspring pairs, and probably
occurred as a result of direct mother-to-infant transmission of the
virus. In other instances, clusters of closely related viruses included
a strain collected from a monkey documented as being recently
infected. No clear association could be established for several of
the closely related strains, and, as previously mentioned, these
infections might have occurred during other social interactions,
such as grooming or wound licking.
SIVagmVer strains from different locations were generally
separated on the phylogenetic trees. Intermixing of strains was also
observed, suggestive of SIVagm spread between communities by
dispersing males. Indeed, although in vervet populations males
range with their social group, they also migrate between groups
upon or shortly after reaching sexual maturity (sometimes multiple
times during the males lifetime) [106,112].
Figure 7. Plasma sCD14 levels in uninfected and SIVagmVer-
infected vervets from South Africa. P value was calculated by the
Mann-Whitney U-test. Animals diagnosed as acutely infected are
denoted by light red circles.
doi:10.1371/journal.ppat.1003011.g007
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Interestingly, the SIVagmVer strains collected from Free State
locations (west of the Drakensberg Mountains) clustered differently
within pol and env trees (Figure 2 and S1) as well as in the gag tree
(data not shown) from those collected from monkeys situated along
the Indian Ocean coast (east of the Drakensberg Mountains).
Given that the geographical spread between coastal monkeys and
those from Free State is similar, the most likely explanation for
these phylogenetic relationships is that the Drakensberg Moun-
tains acted as a barrier (through low temperatures in the elevated
areas) to separate the vervet populations on the two sides. The
Drakensberg Mountains are very old, with an estimated age of 280
million years, which implies that a separation of the vervet
populations could have occurred in a time frame ranging from 3
million years ago (during the AGM spread throughout sub-
Saharan Africa) to 100,000 years go (during the mass migrations
that occurred in the Plio-Pleistocene glacial periods). The
Drakensberg Mountains may also have acted as an effective
barrier to separate different populations of at least two other
species, the common impala (Aepyceros melampus melampus) [113] and
the chacma baboon (Papio ursinus) [114]. We therefore performed
relaxed molecular clock analyses to specify TMRCA of the
SIVagm samples surrounding the Drakensberg Mountains range
to a time-frame spanning 100,000 to 3,000,000 years since the
present for the env tree, and in the pol tree we additionally included
SIV strains of several species and further calibrated the tree based
on isolates from Bioko Island [2]. Molecular clock analysis using
Bayesian techniques is highly dependent on priors that are
specified [115]; however our analysis is in agreement with another
study in which the use of biogeography showed that SIVs are very
old [2], and refuted timing calculations based exclusively on
molecular clocks without regards to biogeographical calibration
points [53].
Taken together, these observations strongly suggest that
SIVagm infection of vervets is more ancient than the most recent
previous estimate [53] and suggests that the concept of host-
dependent evolution (supported by the observation that the four
SIVagm types cluster together in the SIV trees) cannot be
discarded using current molecular clock calibrations, but may
possibly be discernible through the integration of further
biogeographical divergence estimates.
Natural history considerations
It is generally assumed that SIV infection is nonpathogenic in
natural hosts [1,23,44,51,54]. Data supporting this assumption are
derived from the study of captive monkeys and a very limited
number of species (AGMs, sooty mangabeys and mandrills)
[1,23,44,51]. Sporadic cases of progression to AIDS were reported
in each of these species upon infection with their species-specific
viruses [116–118] or with cross-species transmitted SIVs [119].
Large scale studies in wild animals are needed to draw definitive
conclusions about pathogenicity of SIVs in their natural hosts in
the wild, as demonstrated by recent observation that SIVcpz
infection is pathogenic in naturally-infected chimpanzees
[68,69,120]. The fact that such a major effect went undetected
for decades supports the need for systematic assessment of the
natural history of SIV infection in African NHPs in their native
habitat, and not in captive environments (where health status is
controlled, nutrition is monitored and exposure to adventitious
agents that may impact clinical status is limited), to provide
significant information regarding the clinical outcome of SIV
infection in natural hosts.
The main limitation of our assessment of natural history of
SIVagmVer infection in vervets is that only plasma samples were
available, and thus we could not perform immunophenotypic
characterization or in vitro replication studies. We circumvented
this limitation by employing a combination of biomarkers that
could be monitored in plasma.
We report that SIVagmVer infection most likely has a benign
outcome in vervets. BMI were not different between SIV-infected
and SIV-uninfected vervets. Detected levels of viral replication
were high, but in the range of those reported during experimental
studies [27]. In the documented cases of acute SIVagmVer
infection, the VL levels were also in the range of those observed in
experimentally infected monkeys during acute infection [27].
We measured levels of sCD14 to assess the levels of MT, which
is one of the proposed mechanisms of excessive immune activation
that drives HIV/SIV infection to progress to AIDS [88,89].
sCD14 is a surrogate marker for direct measurement of endotoxin
or Gram negative bacteria, and numerous studies have shown a
strong association of increasing sCD14 levels and increasing LPS
levels in plasma in both pathogenic HIV and SIV infections
(presumably due to loss of barrier function in the gut in turn due to
HIV-mediated destruction of GALT) [88,89], and lack of increase
in both markers in the setting of nonpathogenic SIV infections in
natural hosts [30,84,90,121].
It is critical to assess the integrity of the mucosal barrier in a
natural host in the wild, as we and others have previously reported
that lack of MT during chronic infection in AGMs and sooty
mangabeys may be one mechanism of controlling chronic immune
activation and disease progression [30,84]. These studies have
been done using captive NHPs. Wild monkeys are exposed to
many pathogens in a significantly more hostile environment than
are captive animals, which may impact the ability of SIV-infected
monkeys to maintain the barrier. However, we found no
significant difference in the levels of sCD14 between infected
and uninfected vervets in the wild.
In addition to being a surrogate marker of MT, sCD14 is a
marker of macrophage activation, and thus our results also suggest
that there are no significant differences in the levels of macrophage
activation between SIV-infected and uninfected AGMs in the wild.
Lack of chronic immune activation was also supported by the
similar levels of cytokines and chemokines tested in SIVagmVer-
infected and uninfected wild vervets. The only exception was
represented by an increased level of IL-6 in SIVagmVer-infected
animals, which was driven by high levels of this cytokine in acutely
infected monkeys. We and others reported that a transient increase
in immune activation occurs during acute SIV infection in natural
hosts [33,35,36,91,122], which is rapidly resolved with the
transition to chronic infection [30]. Therefore, the similar levels
of cytokine in plasma between SIV-infected and uninfected
animals are somewhat surprising in the context of a significant
number of acute infections in our study sample. This apparent
discrepancy with the results of experimental studies may be due to
the fact that most of the experimental studies involved intravenous
administration of large amounts of virus that may trigger
inflammation and immune activation. Alternatively, as we have
previously shown, the acute increases in levels of plasma cytokines
and chemokines are very transient in natural hosts, being thus
likely that our cross-sectional samples missed such increases.
Figure 8. Cytokine and chemokine levels in uninfected and SIVagmVer-infected vervets from South Africa. P value was calculated by
the Mann-Whitney U-test. Animals diagnosed as acutely infected are denoted by light red circles.
doi:10.1371/journal.ppat.1003011.g008
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Altogether, sCD14 and cytokine/chemokine testing data
support the conclusion that SIVagmVer infection of wild vervets
is not associated with significant increases in levels of immune
activation. Immune activation being the main driver of HIV
disease progression, our results corroborate the clinical assessment
and support a nonprogressive outcome of SIVagmVer infection in
the wild.
Final considerations: Wild vervet populations from South
Africa as an animal model for exposed-seronegative/
exposed-uninfected (ESN/EU) patients
Both clinical experience and a growing medical literature
indicate that some persons who have been exposed to HIV
infection remain uninfected [123]. Although in some instances this
may simply represent good fortune, cohorts of uninfected persons
have been reported who are considered at high risk for infection.
Clarifying the determinants of protection against HIV infection is
a high priority that will require careful selection of high-risk
uninfected cohorts, which should undergo targeted studies of
plausible mediators and broad screening for unexpected determi-
nants of protection. An animal model for ESN/EU may permit
such an assessment while circumventing the major ethical
boundaries to the study of ESN/EU humans. Such an animal
model is not currently available. The SIVmac/RM model is not
relevant for ESN/EU studies because this model was derived for
pathogenesis and vaccine studies (thus employing strains selected
for pathogenicity and not for their transmission characteristics)
[124]. On the other hand, de novo development of such a model in
RMs would be extremely expensive and face major macaque
availability restrictions. In this context, the SIVagmVer-infected
wild vervet cohorts that we identified in South Africa may serve as
a useful model for ESN/EU studies. In these populations, there is
an enormous exposure to SIVagm. However, while up to 80% of
sexually-active adult females are infected with SIVagmVer, the
remaining 20% are uninfected in spite of the presumably massive
potential for exposure to SIV throughout their lives. Thus, field
studies to assess the prevalence and incidence of SIV infection in
the wild and prospectively confirm resistance to infection in a
subset of ESN/EU monkeys, combined with genetic, immunologic
and virologic assessment of the monkeys in the cohorts, may
permit identification of correlates of ESN/EU, an instrumental
leap for designing new therapeutic strategies aimed at preventing
HIV infection.
In conclusion, we report that SIVagmVer is highly prevalent in
wild vervet populations from South Africa, that the virus has long
been present in this population and that coevolution between
SIVagmVer and its natural host, the vervet monkey, resulted in an
infection which has a benign outcome in the wild. More
importantly, our study has identified a potential model for the
study of ESN/EU cases, which has a strong potential to identify
correlates of protection against HIV/SIV infection.
Materials and Methods
Ethics statement
All the animals sampled in this study were used according to
regulations set forth by the Animal Welfare Act. The animal
sampling protocols were approved by the University of Wisconsin-
Milwaukee Institutional Animal Care and Use Committee
(IACUC). Studies at the UCLA and University of Pittsburgh
were carried out through an agreement with the UWM. At the
University of the Free State UFS, ethical clearance was provided
by the Interfaculty Animal Ethics Committee (project no. 13/
2010).
Samples
The study was carried out in feral and semifree vervets (n=225)
living in different areas in South Africa, aged between 6 months
and 10 years (Figure 1). Animals were individually trapped using
established methods [125]. Details on animal capture are provided
as Text S1. Blood was collected through venous puncture. Details
are provided as Text S1. Each monkey included in the study had a
microchip implanted for further identification and to prevent
duplicate sampling. Detailed clinical assessment of the monkeys
(including signs associated with immunodeficiency, i.e., lymph-
adenopathy, low weight, fever or rashes) was performed at the
time of blood collection. Details are provided as Text S1. Upon
collection, plasma was immediately stored at 280uC. A 500 ml
aliquot of plasma from each monkey was available for this study.
Plasma processing and testing strategy
Upon arrival, plasma samples were thawed for RNA extraction
and separated into three aliquots: the first aliquot was used for
testing the prevalence levels of SIV by PCR. Additional SIV
ELISA testing was performed using this aliquot to establish the
stage of acute SIV infection and infant exposure to SIVagm. The
second aliquot was used for quantification of SIVagm VLs by real-
time PCR. Primers and probes were designed based on the
SIVagm integrase sequences. Correlation between VLs and
serology enabled identification of acutely SIV-infected AGMs
[87]. Finally, the third aliquot was used to assess the natural
history of SIVagm infection in the wild by testing surrogate
markers for microbial translocation and immune activation
(sCD14 and cytokine/chemokine levels).
Viral RNA extraction and cDNA synthesis
From each plasma specimen, viral RNA was extracted using the
QIAamp Viral RNA Mini kit (QIAGEN, Germantown, MD).
RNA was eluted and immediately subjected to cDNA synthesis.
Reverse transcription of RNA to single-stranded cDNA was
performed using SuperScript III reverse transcription according to
the manufacturer’s recommendations (Invitrogen, Carlsbad, CA).
In brief, each cDNA reaction included 16RT buffer, 0.5 mM of
each deoxynucleoside triphosphate, 5 mM dithiothreitol, 2 U/ml
RNaseOUT (RNase inhibitor), 10 U/ml of Super-Script III
reverse transcriptase, and 0.25 mM antisense primers SIV-POL-
OR (59-ACB ACY GCN CCT TCH CCT TTC-39), SIV-GAG-B
(59-CCT ACT CCC TGA CAG GCC GTC AGC ATT TCT
TC-39) and SIV-ENV-B (59-AGA GCT GTG ACG CGG GCA
TTG AGG TT-39). The mixture was incubated at 50uC for
60 min, followed by an increase in temperature to 55uC for an
additional 60 min. The reaction was then heat-inactivated at 70uC
for 15 min and treated with 2 U of RNase H at 37uC for 20 min.
The newly synthesized cDNA was used immediately or frozen at
280uC.
Nested PCR and DNA gel extraction
SIVagm RNA was amplified byPCR using Platinium Taq
Polymerase High Fidelity (Invitrogen, Carlsbad, CA). A 600 bp pol
integrase fragment was amplified by nested PCR using outer
primers POL-IS4 (59-CCA GCN CAC AAA GGN ATA GGA
GG-39) and POL-OR and inner primers SIV-POL-IS4 and SIV-
POL-Unipol2 (59-CCC CTA TTC CTC CCC TTC TTT TAA
AA-39) [59,126]. An 846 bp gag fragment was amplified by nested
PCR using outer primers GAG-A (59-AGG TTA CGG CCC
GGC GGA AAG AAA A-39) and GAG-B, and inner primers
GAG-C (59-AGT ACA TGT TAA AAC ATG TAG TAT GGG
C-39) and GAG-F (59-CCT TAA GCT TTT GTA GAA TCT
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ATC TAC ATA-39) [127]. Finally, a 900-bp env fragment
encompassing the V3-V5 gp120 region and the 59 end of gp41
envelope regions was amplified by nested PCR using outer primers
ENV-A (59-GAA GCT TGT GAT AAA ACA TAT TGG AT-39)
and ENV-B, and inner primers ENV-C (59-GTG CAT TGT
ACA GGG TTA ATG AAT ACA ACA G-39) and ENV-D (59-
TTC TTC TGC TGC AGTA TCC CAG CAA G-39) [128].
Nested PCR products were subjected to 1% agarose (Invitrogen,
Carlsbad, CA) gel electrophoresis and extracted and purified by
QIAquick Gel Extraction kit (QIAGEN, Germantown, MD).
DNA sequencing
SIV gene amplicons were directly sequenced by the University
of Pittsburgh Genomics and Proteomics Core laboratories (GPCL)
using the nested PCR primers. Individual sequence for each
amplicon was edited and inspected using BioEdit 7.1.3. Sequences
were translated for analyses on the V3–V5 region of the
SIVagmVer envelope with BioEdit.
Phylogenetic analysis
The gag, pol and env nucleotide sequence alignments were
aligned with reference sequences obtained from the Los Alamos
National Laboratory HIV Sequence Database (http://hiv-web.
lanl.gov). The alignment for the pol region included nucleotide
sequences sampled from the island of Bioko [2]. Newly derived
SIV sequences were aligned using MUSCLE sequence alignment
software [129] and alignments were edited manually where
necessary.
Separate phylogenetic trees for each of the genes were inferred
by maximum-likelihood using PhyML 3.0 [130], with a GTR
substitution model, gamma-distributed rate heterogeneity at sites
and an SPR tree search. Nonparametric bootstrap analysis with
1,000 replicates was performed to assess the reliability of
branching order. In addition, calibrated molecular clock trees
were calculated using BEAST v1.7.3 [115] to infer likely MRCA
dates between different lineages. For molecular clock analysis, we
used an HKY substitution model with gamma-distributed rate
heterogeneity among sites and an uncorrelated lognormal relaxed
molecular clock. A Yule tree prior was used for the pol region, and
a constant size coalescent for the env region. Evolutionary rate was
calibrated by setting a uniform prior bounded by 10,000 and
3,000,000 years, as TMRCA of SIVagm isolates sampled from
areas surrounding the Drakensberg Mountains. For the pol region,
a normal distribution with a mean of 10,000 years and a standard
deviation of 1,000 years was additionally used to calibrate
TMRCA of Bioko and mainland SIVdrl sequences. Chains were
run for 107–108 states and ESS values were high (.300). Analysis
of the molecular clock trees was performed using Tracer v1.5
(http://tree.bio.ed.ac.uk/software/tracer/), and trees were in-
ferred by maximum clade credibility with mean node heights
using TreeAnnotator v1.7.3, and visualized using FigTree v1.3.1
(http://tree.bio.ed.ac.uk/software/figtree/). To test for signals of
recombination in the dataset, we ran the Neighbor-Net algorithm
implemented in SplitsTree [131] to infer phylogenetic networks
for the env and pol regions.
Viral load quantification
We used the generated pol alignment to design specific primers
and probe for VL quantification in wild vervets: pol-F (59-GTA
GCC AGT GGG TTC ATA GAA GCA-39), pol-R (59-CAT
TGC CTT TAC TTC CTG TGA AAT GA-39) and pol-Probe
(59-/56-FAM/TAG AGA AAC/ZEN/AGG AAA AGA AAC
AGC AA/3IABkF/-39). Primers and probe were synthesized by
IDTDNA (Coralville, IA) and were used in a one-step real-time
PCR assay with TaqMan One Step PCR Master Mix (Applied
Biosystems, Branchburg, NJ). Real-time PCR was performed in
MicroAmp Optical 96-well plates (Applied Biosystems, Branch-
burg, NJ) by mixing the OneStep RT-PCR Enzyme Mix with 5 ml
isolated RNA in a 50 ml final reaction volume. Real-time PCR
conditions were as follows: 30 min at 50uC, 15 min at 95uC,
followed by 45 cycles of 95uC for 15 s and 60uC for 1 min.
Dilutions of all components were made using sterile RNase-free
water. Data were collected and analyzed using the PE Applied
Biosystems software provided. RNA copies/well were adjusted to
copies per milliliter of original plasma. Samples were tested in
duplicate and the number of RNA copies determined by
comparison with a standard curve obtained using known amounts
of SIV-pol RNA. The SIVagm RNA standard was produced by
cloning one of the SIVagmVerpol gene fragments into Vector
pBluescript SK+ and linearizing it by Xba I as a DNA template for
RNA in vitro transcription. Standard RNA was produced by using
MEGAscript kit (Applied Biosystems, Branchburgh, NJ), accord-
ing to the manufacturer’s instructions. Briefly, the transcription
reaction system was assembled at room temperature and mixed
thoroughly, followed by incubation at 37uC for 4 hours. One
microliter of TURBO DNase was added to the reaction mixture
followed by incubation at 37uC for 15 minutes to digest the DNA
template. RNA was recovered by Lithium chloride precipitation.
The amount of RNA was quantified at A260, aliquoted and
immediately stored at 280uC.Detection limit of the SIVagmVer
quantification assay was 100 copies/ml.
Serology
Based on the env sequence data, a peptide mapping the
immunodominant region in the Gp41 transmembrane glycopro-
tein was synthesized and used in a peptide enzyme linked
immunosorbent assay (ELISA), as described [132]. The inferred
peptide sequence was TALEKYLEDQARLNVWGCAWKQVC,
and this sequence was very well conserved between different
SIVagmVer isolates, including previously reported reference
strains from Kenya and Ethiopia [9,10,93]. The Gp36 peptide
was synthesized to a purity of at least 90% (Fisher Scientific, USA)
and the assay was performed as previously reported [132]. The
cut-off of the reaction was arbitrarily set at 0.20, as per previous
reports [132].
Microbial translocation (MT)
MT was assessed using the levels of soluble CD14 (sCD14) as a
surrogate marker [89]. CD14 is a transmembranous protein,
which also exists in a soluble form (sCD14; both as a shed
membrane form and an alternatively spliced form), as a part of the
complex that presents endotoxin (lipopolysaccharide or LPS) to
TLR4 on monocytes. When monocytes are activated, ectodomain
shedding results in increased sCD14 levels. sCD14 is therefore
surrogate for direct measurement of endotoxin or Gram negative
bacteria which translocate from the intestinal lumen to general
circulation as a result of the immunologic injury inflicted at the
mucosal level by the pathogenic HIV/SIV infection [88–90,121].
sCD14 levels were measured using a quantitative sandwich
enzyme immunoassay technique (Quantikine Human sCD14
Immunoassay, R&D Systems, Minneapolis, MN). The detection
limit of this kit is 200 ng/mL and can range up to 5000 ng/mL,
with an interassay coefficient of variability ranging between 7.19%
and 10.9%.
Cytokine and chemokine testing
Cytokine testing in plasma was done using a sandwich
immunoassay-based protein array system, Cytokine Monkey
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Magnetic 28-Plex Panel (Invitrogen, Camarillo, CA), as instructed
by the manufacturer, and results were read by the Bio-Plex array
reader (Bio-Rad Laboratories, Hercules, CA), which uses Luminex
fluorescent-bead-based technology (Luminex Corporation, Austin,
TX).
Statistical analyses
Statistical analyses were performed to analyze the results of viral
load, sCD14 and cytokine testing using Mann-Whitney U-tests
and Prism 4.0 software (Prism, Irvine, CA).
Nucleotide sequence accession numbers
The nucleotide sequences of the pol and env sequences from
SIVagmVer-infected vervets from South Africa were deposited in
the GeneBank (accession numbers: JX462308-JX462444).
Supporting Information
Figure S1 Maximum likelihood trees for env gene of the
newly derived SIVagmVer sequences from wild vervets
in South Africa.Maximum likelihood estimates were performed
using 1000 replicate bootstrap analysis. Internal nodes indicate
level of support values for internal branching. Sequences are
colored depending on the region in which the sequences were
sampled, with red indicating sequences from Free State, green
indicating sequences from KwaZulu-Natal, and blue indicating
sequences from Eastern Coast territories. In addition, sequences
colored in gray are sampled from the Riverside Wildlife
Rehabilitation and Environmental Education Centre (RWREC),
Letsitele, Limpopo semifree colony that is housing released pets or
animals with health problems, and their origin is unknown, and
sequences colored in black indicate outgroup sequences. The
strain nomenclature includes the identification number, monkey
status (M-male, F-female; I-infant; J-juvenile and A-adult), and the
site and the state of origin (FS-Free State; KZN-KwaZulu Natal;
EC-Eastern Cape).
(TIFF)
Figure S2 SplitsTree showing the pol gene of South
African SIVagmVer sequences. Nodes are colored by the
region in which they were sampled, with red, blue and green
denoting Free State, East Coast and KwaZulu-Natal, respectively.
Potentially interesting recombinants have been circled, including
VMT17083-IM-Gariep_FS and a cluster indicating possible
mixing between East Coast and KwaZulu-Natal sequences.
(TIFF)
Figure S3 Comparative body mass index (BMI) assess-
ment based on age and location in SIV-infected and SIV
uninfected wild vervet monkeys (Chlorocebus pygeri-
thrus) from South Africa.
(TIFF)
Table S1 SIV prevalence in vervet monkeys from South
Africa based on location of collected samples.
(DOC)
Table S2 Age- and sex-related prevalence of SIVagmVer
in semifree vervets from Riverside Wildlife Rehabilita-
tion and Education Center, Letsitele, Limpopo.
(DOC)
Table S3 Estimates of evolutionary divergence over
sequence pairs between groups. The number of base
substitutions per site6standard error estimate(s) from averaging
over all sequence pairs between groups are shown6 Analyses were
conducted using the Maximum Composite Likelihood model [1].
The rate variation among sites was modeled with a gamma
distribution (shape parameter = 0.5). env analysis involved 81
nucleotide sequences. All positions containing gaps and missing
data were eliminated. There were a total of 822 positions in the
final dataset for env. pol analysis involved 98 nucleotide sequences.
All positions containing gaps and missing data were eliminated.
There were a total of 574 positions in the final pol dataset.
Evolutionary analyses were conducted in MEGA5 [2].
(DOC)
Table S4 Most recent common ancestor (MRCA) esti-
mates using relaxed molecular clocks to incorporate
biogeographical assumptions. Calibration for the env gene is
based on time to MRCA (TMRCA) of SIVagm sequences
sampled around the Drakensberg Mountains, presumed to be
100,000–3,000,000 years of age. Calibration of the pol gene is
based on TMRCA of SIVagm sequences as before, as well as
SIVdrl sequences sampled from the Bioko Island of Equatorial
Guinea, presumed to have been isolated for approximately 10,000
years. These estimates indicate that SIV is potentially considerably
older than previous estimates, and refute timing estimates based
exclusively on molecular clocks without calibration.
(DOC)
Text S1 Details on animal origin, animal capture,
sampling methodology and clinical assessment.
(DOC)
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